Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

Todd Neale

March 05, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Todd Neale

January 20, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCTMD’s Top 10 Most Popular Stories for October 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Four-Year Outcomes From the EVOLUT Low Risk Trial

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

What’s Going to Be Hot at TCT 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

October 2023 News Roundup

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content